Status:
COMPLETED
Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborating Sponsors:
Emory University
Conditions:
Pneumococcal Infections
Eligibility:
All Genders
50-64 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to learn whether or not giving a tetanus/diphtheria vaccination ("tetanus shot") before giving pneumococcal vaccine makes the pneumococcal vaccine more effective without c...
Detailed Description
The only vaccine licensed in the United States for protecting adults against pneumococcal disease (PPV23) protects against invasive disease in observational studies but has generally been poorly effec...
Eligibility Criteria
Inclusion
- Exclusion Criteria:
- Participation in any other investigational clinical trials except purely observational studies within 4 weeks prior to study start
- Any vaccination within 2 weeks prior to first study vaccine
- Evidence of systemic or local infection within one week prior to first study vaccine
- HIV infection
- Renal failure
- Receipt of a pneumococcal or Td vaccine within 5 years
- Current receipt of therapy for neoplastic disease
- Current receipt of immunosuppressive therapy
- Terminal illness withlife expectancy less than 3 months
Exclusion
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00164411
Start Date
January 1 2004
End Date
March 1 2005
Last Update
March 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University School of Medicine
Atlanta, Georgia, United States, 30322